Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion type Assertion NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_head.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion description "[In addition, the simultaneous presence of KIR2DS5 gene and HLA-C C1 allotype exhibited an even stronger protective effect on ankylosing spondylitis (p=0.0003, OR=0.35, CI=0.19-0.65), whereas a lack of KIR2DS5 and the presence of the HLA-C C2 allotype was associated with ankylosing spondylitis (p=0.0017, OR=1.92, CI=1.28-2.89), whereas a lack of KIR2DS5 and presence of C1 allotype was associated with rheumatoid arthritis (p=0.005, OR=1.47, CI=1.13-1.92).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion evidence source_evidence_literature NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion SIO_000772 20865034 NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion wasDerivedFrom befree-2016 NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.
- NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_assertion wasGeneratedBy ECO_0000203 NP841556.RAWPHgy5zCNxxy0TpIi8mH6tDk74QVr26JUfBxOo6Aays130_provenance.